Saturday, April 5, 2014

ProMetic's PBI-4050 Shown to Reduce Blood Glucose and Kidney Fibrosis in Preclinical Models of Human Type II Diabetes and Kidney Disease


ProMetic's PBI-4050 Shown to Reduce Blood Glucose and Kidney Fibrosis in Preclinical Models of Human Type II Diabetes and Kidney Disease

… field of fibrosis, cancer and autoimmune diseases/inflammation. Headquartered in Laval (Canada …See all stories on this topic








Germs Rule the World

… in research into gastrointestinal and autoimmune diseases, driven by the growing awareness …See all stories on this topic




Pulmonary Hypertension Deaths Have Increased Over Past Decade, According to Report

… , obstructive sleep apnea, and certain autoimmune disease such as rheumatoid arthritis. The …See all stories on this topic




UNOV Announces Name Change, Symbol and Enters the Fast Growing Health, Nutrition, Wellness and Alternative Medicine Markets

… arthritis, cerebral ischemia, social anxiety, autoimmune disorder, eczema, psoriasis, digestive diseases and …See all stories on this topic




ProMetic's PBI-4050 Shown to Reduce Blood Glucose and Kidney Fibrosis in Preclinical Models of Human Type II Diabetes and Kidney Disease

No comments:

Post a Comment